SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-073330
Filing Date
2024-06-14
Accepted
2024-06-14 07:18:05
Documents
82
Period of Report
2024-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q engn-20240430.htm   iXBRL 10-Q 2046223
2 EX-10.2 engn-ex10_2.htm EX-10.2 124801
3 EX-31.1 engn-ex31_1.htm EX-31.1 18846
4 EX-31.2 engn-ex31_2.htm EX-31.2 18419
5 EX-32.1 engn-ex32_1.htm EX-32.1 9573
6 EX-32.2 engn-ex32_2.htm EX-32.2 9584
  Complete submission text file 0000950170-24-073330.txt   9841864

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT engn-20240430.xsd EX-101.SCH 1862050
86 EXTRACTED XBRL INSTANCE DOCUMENT engn-20240430_htm.xml XML 1367321
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-41854 | Film No.: 241043142
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)